We are live on
!
Find out more
BDLIB
Banque de Luxembourg Investments (BLI) Portfolio holdings
AUM
$3.34B
1-Year Est. Return
11.13%
This Fund
S&P 500
This Quarter
Est. Return
-4.8%
1 Year Est. Return
+11.13%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.34B
AUM Growth
-$67.6M
(-2%)
Cap. Flow
-$7.31M
Cap. Flow
% of AUM
-0.22%
Top 10 Holdings %
Top 10 Hldgs %
33.03%
Holding
179
New
1
Increased
–
Reduced
–
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$71.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$41.6M |
| 2 |
Zebra Technologies
ZBRA
|
+$15.8M |
| 3 |
Xylem
XYL
|
+$12.4M |
| 4 |
Yum China
YUMC
|
+$9.49M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.99% |
| 2 | Industrials | 14.99% |
| 3 | Healthcare | 14.84% |
| 4 | Consumer Discretionary | 8.87% |
| 5 | Communication Services | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Procter & Gamble
PG
$338B
| $18.6M | 0.56% |
130,981
| – | – |
|
52
Jack Henry & Associates
JKHY
$11.1B
| $18M | 0.54% |
99,400
| – | – |
|
53
Equifax
EFX
$20.5B
| $17.9M | 0.54% |
82,540
| – | – |
|
54
Clorox
CLX
$11.9B
| $16.8M | 0.5% |
169,720
| – | – |
|
55
Tyler Technologies
TYL
$12.5B
| $15.7M | 0.47% |
34,820
| – | – |
|
56
Nordson
NDSN
$16.9B
| $15.5M | 0.46% |
64,600
| – | – |
|
57
Newmont
NEM
$100B
| $15.5M | 0.46% |
154,500
| – | – |
|
58
Chemed
CHE
$7.18B
| $15M | 0.45% |
35,500
| – | – |
|
59
Berkshire Hathaway Class B
BRK.B
$1.11T
| $14.9M | 0.45% |
30,000
| – | – |
|
60
ServiceNow
NOW
$118B
| $14.6M | 0.44% |
96,105
| – | – |
|
61
MSCI
MSCI
$41.8B
| $14.5M | 0.43% |
25,240
| – | – |
|
62
Edwards Lifesciences
EW
$51.1B
| $14.4M | 0.43% |
169,530
| – | – |
|
63
UnitedHealth
UNH
$377B
| $13.9M | 0.42% |
42,683
| – | – |
|
64
Ametek
AME
$55.9B
| $13.9M | 0.42% |
68,430
| – | – |
|
65
West Pharmaceutical
WST
$24.5B
| $13.6M | 0.41% |
49,900
| – | – |
|
66
Veeva Systems
VEEV
$33.5B
| $13.3M | 0.4% |
60,265
| – | – |
|
67
Texas Pacific Land
TPL
$28B
| $13.2M | 0.4% |
45,900
| – | – |
|
68
Bristol-Myers Squibb
BMY
$134B
| $13.2M | 0.39% |
247,000
| – | – |
|
69
Manhattan Associates
MANH
$10.9B
| $12.7M | 0.38% |
74,100
| – | – |
|
70
IQVIA
IQV
$38.4B
| $12.5M | 0.37% |
55,825
| – | – |
|
71
Paychex
PAYX
$41.9B
| $12.3M | 0.37% |
109,965
| – | – |
|
72
Globus Medical
GMED
$11.1B
| $11.8M | 0.35% |
136,500
| – | – |
|
73
Burlington
BURL
$23.2B
| $11.8M | 0.35% |
41,600
| – | – |
|
74
Booking.com
BKNG
$149B
| $11.7M | 0.35% |
54,950
| – | – |
|
75
Core & Main
CNM
$8.56B
| $11.7M | 0.35% |
224,400
| – | – |
|
Similar funds
ECA
QCG
HP
5NCM
DIA
EFM
VFCM
DFO
Banque de Luxembourg Investments (BLI)'s Q1 2026 Portfolio in Review
As of Q1 2026, Banque de Luxembourg Investments (BLI) held 179 positions worth $3.34B, down 2% from $3.41B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 2.8%. Banque de Luxembourg Investments (BLI) opened 1 new position and exited 4, leaving the 179-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 29% a quarter earlier, followed by Industrials and Healthcare.
- Banque de Luxembourg Investments (BLI)'s largest Q1 2026 buy was AstraZeneca: 372,869 shares worth $69M.
- Banque de Luxembourg Investments (BLI) fully exited Zoetis in Q1 2026, selling an estimated $41.6M.
- Banque de Luxembourg Investments (BLI)'s ten largest holdings make up 33% of its $3.34B portfolio in Q1 2026.
- Banque de Luxembourg Investments (BLI) opened 1 new position and closed 4 in Q1 2026.
- Banque de Luxembourg Investments (BLI)'s portfolio value fell 2% quarter-over-quarter to $3.34B.
Based on Banque de Luxembourg Investments (BLI)'s 13F filing for Q1 2026, filed 15 May 2026.